Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1998 Sep;89(9):910–915. doi: 10.1111/j.1349-7006.1998.tb00648.x

Immunological Quantitation of DT‐Diaphorase in Carcinoma Cell Lines and Clinical Colon Cancers: Advanced Tumors Express Greater Levels of DT‐Diaphorase

Koji Mikami 1,2, Mikihiko Naito 1, Tatsuaki Ishiguro 1,3, Hideaki Yano 1,3, Akihiro Tomida 1, Takeshi Yamada 4, Noritake Tanaka 4, Takayuki Shirakusa 2, Takashi Tsuruo 1,5,✉
PMCID: PMC5921949  PMID: 9818026

Abstract

NAD(P)H:quinone oxidoreductase (DT‐diaphorase; DTD) plays a major role in activating mitomycin C (MMC) in human colon and gastric carcinoma cell lines. Thus, measurement of DTD in clinical tumor samples could be beneficial in designing adjuvant chemotherapy. We explored immunological quantitation of DTD protein using a monoclonal antibody against DTD, demonstrating a close correlation between protein expression and enzyme activity of DTD in colon and gastric carcinoma cell lines and in colorectal tumor samples. This indicates that such immunoblot analysis is a simple alternative method for quantitating DTD in clinically excised samples. In most colorectal tumor samples, the tumors expressed larger amounts of DTD than did the peripheral normal tissues, suggesting a selective toxicity of MMC toward tumor cells. Also tumors with nodal metastases showed significantly higher DTD levels than did tumors without metastasis. These results raise the possibility that DTD expression is related to tumorigenesis and malignant progression of colorectal tumors. Measurement of DTD by the immunological method described here could be beneficial in designing a rational adjuvant chemotherapy with MMC.

Keywords: key words, Mitomycin C, DT‐diaphorase, Immunoblot, Metastasis, Colon carcinoma

Full Text

The Full Text of this article is available as a PDF (185.4 KB).

REFERENCES

  • 1. ) Tomasz , M. and Lipman , R.Reductive mechanism and alkylating activity of mitomycin C induced by rat liver microsomes . Biochemistry , 20 , 5056 – 5061 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Pan , S. S. , Andrews , P. A. , Glover , C. J. and Bachur , N. R.Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH‐cytochrome P‐450 reductase and xanthine oxidase . J. Biol. Chem. , 259 , 959 – 966 ( 1984. ). [PubMed] [Google Scholar]
  • 3. ) Hodnick , W. F. and Sartorelli , A. C.Reductive activation of mitomycin C by NADH:cytochrome b5 reductase . Cancer Res. , 53 , 4907 – 4912 ( 1993. ). [PubMed] [Google Scholar]
  • 4. ) Gustafson , D. L. and Pritsos , C. A.Enhancement of xanthine dehydrogenase mediated mitomycin C metabolism by dicoumarol . Cancer Res. , 52 , 6936 – 6939 ( 1992. ). [PubMed] [Google Scholar]
  • 5. ) Jaiswal , A. K. , McBride , O. W. , Adesnik , M. and Nebert , D. W.Human dioxin inducible cytosolic NAD(P)H:menadione oxidoreductase. cDNA sequence and localization of gene to chromosome 16 . J. Biol. Chem. , 263 , 13572 – 13578 ( 1988. ). [PubMed] [Google Scholar]
  • 6. ) Pan , S. S. , Forrest , G. L. , Akman , S. A. and Hu , L. T.NAD(P)H:quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells . Cancer Res. , 55 , 330 – 335 ( 1995. ). [PubMed] [Google Scholar]
  • 7. ) Traver , R. D. , Horikoshi , T. , Danenberg , K. D. , Stadlbauer , T. H. , Danenberg , P. V. , Ross , D. and Gibson , N. W.NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT‐diaphorase activity and mitomycin sensitivity . Cancer Res. , 52 , 797 – 802 ( 1992. ). [PubMed] [Google Scholar]
  • 8. ) Marshall , R. S. , Paterson , M. C. and Rauth , A. M.Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions . Br. J. Cancer , 59 , 341 – 346 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. ) Keyes , S. R. , Rockwell , S. and Sartorelli , A. C.Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro . Cancer Res. , 45 , 213 – 216 ( 1985. ). [PubMed] [Google Scholar]
  • 10. ) Siegel , D. , Gibson , N. W. , Preusch , P. C. and Ross , D.Metabolism of mitomycin C by DT‐diaphorase: role in mitomycin C‐induced DNA damage and cytotoxicity in human colon carcinoma cells . Cancer Res. , 50 , 7483 – 7489 ( 1990. ). [PubMed] [Google Scholar]
  • 11. ) Begleiter , A. , Robotham , E. , Lacey , G. and Leith , M. K.Increased sensitivity of quinone resistant cells to mitomycin C . Cancer Lett. , 45 , 173 – 176 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Rockwell , S. , Keyes , S. R. and Sartorelli , A. C.Modulation of the cytotoxicity of mitomycin C to EMT6 mouse mammary tumor cells by dicoumarol in vitro . Cancer Res. , 48 , 5471 – 5474 ( 1988. ). [PubMed] [Google Scholar]
  • 13. ) Fitzsimmons , S. A. , Workman , P. , Grever , M. , Paull , K. , Camalier , R. and Lewis , A. D.Reductase enzyme expression across the National Cancer Institute tumor cell line panel; correlation with sensitivity to mitomycin C and EO9 . J. Natl. Cancer Inst. , 88 , 259 – 269 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Lee , J. H. , Naito , M. , Nakajima , M. and Tsuruo , T.Isolation and characterization of a mitomycin C‐resistant variant of human colon carcinoma HT‐29 cells . Cancer Chemother. Pharmacol. , 33 , 215 – 220 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Mikami , K. , Naito , M. , Tomida , A. , Yamada , M. , Sirakusa , T. and Tsuruo , T.DT‐diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric carcinoma cell lines . Cancer Res. , 56 , 2823 – 2826 ( 1996. ). [PubMed] [Google Scholar]
  • 16. ) Ernster , L.DT‐diaphorase . Methods Enzymol. , 10 , 309 – 317 ( 1967. ). [Google Scholar]
  • 17. ) Watanabe , M. , Komeshima , N. , Naito , M. , Isoe , T. , Otake , N. and Tsuruo , T.Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug‐resistant cells . Cancer Res. , 51 , 157 – 161 ( 1991. ). [PubMed] [Google Scholar]
  • 18. ) Tsuruo , T. , Iida , H. , Tsukagoshi , S. and Sakurai , Y.Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil . Cancer Res. , 41 , 1967 – 1972 ( 1981. ). [PubMed] [Google Scholar]
  • 19. ) Benson , A. M. , Hunkeler , M. J. , and Talalay , P.Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity . Proc. Natl. Acad. Sci. USA , 77 , 5216 – 5220 ( 1980. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. ) Schor , N. A. and Cornelisse , C. J.Biochemical and quantitative histochemical study of reduced pyridine nucleotide dehydrogenation by human colonic carcinoma . Cancer Res. , 43 , 4850 – 4855 ( 1983. ). [PubMed] [Google Scholar]
  • 21. ) Schlager , J. J. and Powis , G.Cytosolic NAD(P)H:(quinone‐acceptor) oxidoreductase in human normal and tumor tissue: effects of cigarette smoking and alcohol . Int. J. Cancer , 45 , 403 – 409 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) de Waziers , I. , Cugnenc , P. H. , Berger , A. , Leroux , J. P. and Beaune , P. H.Drug‐metabolizing enzyme expression in human normal peritumoral and tumoral colorectal tissue samples . Carcinogenesis , 12 , 905 – 909 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Cresteil , T. and Jaiswal , A. K.High levels of expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin . Biochem. Pharmacol. , 42 , 1021 – 1027 ( 1991. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES